Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus - Liou, Jyh-Ming; Malfertheiner, Peter; Lee, Yi-Chia; Sheu, Bor-Shyang; Sugano, Kentaro; Cheng, Hsiu-Chi; Yeoh, Khay-Guan; Hsu, Ping-I; Goh, Khean-Lee; Mahachai, Varocha; Gotoda, Takuji; Chang, Wei-Lun; et al. (Gut, 2020)
Keywords: Agreements; Anti-Bacterial Agents - administration & dosage; Antibiotics; Antimicrobial Stewardship; Atrophy; cancer prevention; Cancer screening; Clinical Decision-Making; Colorectal cancer; Colorectal carcinoma; Cost-Benefit Analysis; Delphi Technique; Disease prevention; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Early Detection of Cancer; Endoscopy; Endoscopy, Gastrointestinal; Gastric cancer; Gastritis; Gastritis, Atrophic - microbiology; Gastritis, Atrophic - prevention & control; Gastroenterology; Gastroesophageal Reflux; Gastrointestinal Microbiome; Genetic Markers; Global Health; Guidelines; Helicobacter Infections - diagnosis; Helicobacter Infections - drug therapy; Helicobacter Infections - epidemiology; Helicobacter pylori; helicobacter pylori - treatment; Human health and pathology; Humans; Infections; Intestine; Life Sciences; Metabolic Syndrome; Metaplasia; Metaplasia - microbiology; Metaplasia - prevention & control; Microbiota; Older people; Population; Population studies; Proton Pump Inhibitors - administration & dosage; Reinfection; screening; Stomach Neoplasms - epidemiology; Stomach Neoplasms - microbiology; Stomach Neoplasms - prevention & control; Working groups; Young adults; Taiwan; helicobacter pylori; screening; cancer prevention; gastric cancer; helicobacter pylori - treatment